|Articles|April 1, 2020
- Pharmaceutical Executive-04-01-2020
- Volume 40
- Issue 4
Pharmaceutical Executive, April 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 6 years ago
HBA's Woman of the Year 2020: A Motivated Missionalmost 6 years ago
Doubling Down on D&Ialmost 6 years ago
COVID-19 Ripple Effects for Pharmaalmost 6 years ago
Prescribing Patterns: How to Get Ahead of the Trendsalmost 6 years ago
There’s No Easing the Price-vs.-Value Debatealmost 6 years ago
Payer Perspectives on Gene Therapy Reimbursementalmost 6 years ago
Covid-19 Pandemic Thrusts Biopharma R&D to Forefrontalmost 6 years ago
Transforming the CIO Role to Embrace Digital Healthalmost 6 years ago
Country Report: The Czech RepublicNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx Is Live and Complicated
2
Veradermics Raises $256 Million in Upsized Initial Public Offering
3
FDA Approves Vybrique to Treat Adult Men with Erectile Dysfunction
4
Pharmaceutical Executive Daily: FDA Approves First and Only Oral Film Treatment for Erectile Dysfunction
5
